Luminal B Breast Cancer Coexpressing p62 and ALDH1A3 Is Less Susceptible to Radiotherapy. Ozaki A, Matsuda A, Maemura Y, Tada Y, et al. Anticancer Res 2024;44:37-47.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ozaki A, Matsuda A, Maemura Y, Tada Y, et al. Luminal B Breast Cancer Coexpressing p62 and ALDH1A3 Is Less Susceptible to Radiotherapy. Anticancer Res 2024;44:37-47.
PMID: 38160009